Article Text

Download PDFPDF

269 A prospective study of factors predicting morbidity and mortality in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian malignancy
  1. VK Ahuja1,
  2. S Somashekar2,
  3. K Ashwin2,
  4. S Zaveri2,
  5. C Rohit Kumar2,
  6. A Rauthan3 and
  7. Y Ramya2
  1. 1Manipal Comphrensive Cancer Centre- Manipal Hospital- Bengaluru, Gynec-Oncology, Bengaluru, India
  2. 2Manipal Comphrensive Cancer Centre- Manipal Hospital- Bengaluru, Surgical Oncology, Bengaluru, India
  3. 3Manipal Comphrensive Cancer Centre- Manipal Hospital- Bengaluru, Medical Oncology, Bengaluru, India


Objectives The risk of morbidity and mortality associated with CRS & HIPEC is substantial enough to make any surgeon think twice before adopting it. Knowing the factors that will predict morbidity would help us optimize outcomes & improve care. This study is an attempt to find such factors that predict morbidity.

Methods Patients diagnosed of peritoneal carcinomatosis from epithelial ovarian malignancy underwent CRS+ HIPEC from March 2012 to December 2017. All data prospectively entered in the HIPEC registry was analysed with main focus on morbidity and factors predicting morbidity .

Results Out of 110 patients, 20, 55,35 underwent upfront, interval & secondary CRS+HIPEC respectively. Mean duration of surgery was 9.5 hours, blood loss 1250 mL & PCI 17. Total, upper & pelvic peritonectomy with glissons capsulectomy & mesenteric stripping was done in 42.5%, 68.1%, 69.3%, 14.7% & 4.3%respectively. Multivisceral , diaphragmatic & bowel resections were done in 20.9%, 40.5% & 57.5% respectively. G3-G5 morbidity was noted in 40%, major being surgical 30%, hematological 20%, electrolyte imbalances 19%. Performance status, mean PCI >14, duration of surgery >10 hours, multivisceral resections, upper quadrant peritonectomy & more than one anastomosis were found to be significant factors predicting morbidity on univariate analysis. On multivariate analysis performance status & upper quadrantectomy were significant factors.

Conclusions CRS + HIPEC for advanced epithelial ovarian malignancy can be done with acceptable morbidity & mortality. A dedicated team is a absolute necessity. We should be more cautious & give extra attention to patients with above mentioned risk factors to improve the quality of care & optimize outcomes with CRS+ HIPEC.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.